Characteristics of patients treated for pulmonary arterial hypertension in real-world database representing a large US health plan

J. Pruett (South San Francisco, CA, United States of America), M. Hull (Eden Prairie, MN, United States of America), C. Elliott (Eden Prairie, MN, United States of America), Y. Tsang (South San Francisco, CA, United States of America), W. Drake (South San Francisco, CA, United States of America)

Source: International Congress 2019 – Pulmonary hypertension: clinical
Session: Pulmonary hypertension: clinical
Session type: Thematic Poster
Number: 4746
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pruett (South San Francisco, CA, United States of America), M. Hull (Eden Prairie, MN, United States of America), C. Elliott (Eden Prairie, MN, United States of America), Y. Tsang (South San Francisco, CA, United States of America), W. Drake (South San Francisco, CA, United States of America). Characteristics of patients treated for pulmonary arterial hypertension in real-world database representing a large US health plan. 4746

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of pulmonary hypertension (PH) on healthcare resource utilization and costs in patients with portal hypertension
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


First and second line treatment pattern among pulmonary hypertension patients enrolled in a managed care health plan
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011


Optimising the management of pulmonary arterial hypertension patients: emergency treatments
Source: Eur Respir Rev 2010 19: 204-211
Year: 2010



Use of a telemedicine application for training and follow up of patients with pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008

Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset
Source: ERJ Open Res, 7 (4) 00431-2021; 10.1183/23120541.00431-2021
Year: 2021



Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021
Year: 2021



Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


An international survey of current pulmonary arterial hypertension (PAH) management
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012


REVEAL: a contemporary US pulmonary arterial hypertension registry
Source: Eur Respir Rev 2012; 21: 8-18
Year: 2012


The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



Treatment options for paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 321-330
Year: 2010



Hispanic patients with pulmonary arterial hypertension: Preliminary results from a contemporary national registry
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Critical care admissions in patients with pulmonary arterial hypertension.
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

A survey of the needs and experiences of pulmonary hypertension patients in the UK
Source: Eur Respir J 2002; 20: Suppl. 38, 26s
Year: 2002

Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014



The changing landscape of pulmonary arterial hypertension and implications for patient care
Source: Eur Respir Rev 2014; 23: 450-457
Year: 2014



Impact of initiation of sildenafil on patterns of healthcare utilization and cost in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009


TOPP: the first international registry in pediatric pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008


Impact of functional class change on survival in patients with pulmonary arterial hypertension in the REVEAL registry
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011